| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 10.686 | 10.729 | 7.132 | 5.244 | 3.913 | 0 | 0 | 408 | 91 | 0 |
| Total Income - EUR | 10.686 | 10.729 | 7.132 | 5.244 | 3.922 | 0 | 0 | 408 | 91 | 3.015 |
| Total Expenses - EUR | 3.152 | 2.116 | 3.607 | 2.883 | 1.456 | 525 | 607 | 458 | 545 | 511 |
| Gross Profit/Loss - EUR | 7.534 | 8.612 | 3.525 | 2.362 | 2.466 | -525 | -607 | -51 | -454 | 2.505 |
| Net Profit/Loss - EUR | 7.213 | 8.291 | 3.311 | 2.205 | 2.348 | -525 | -607 | -63 | -454 | 2.172 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Citotest Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 1.116 | 562 | 18 | 18 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 10.674 | 16.169 | 15.741 | 15.476 | 15.483 | 11.750 | 10.903 | 11.380 | 6.747 | 8.881 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 91 | 87 |
| Cash | 10.674 | 16.169 | 15.741 | 15.476 | 15.483 | 11.750 | 10.903 | 11.380 | 6.656 | 8.794 |
| Shareholders Funds | 10.735 | 15.576 | 15.340 | 12.536 | 11.269 | 10.531 | 9.690 | 3.573 | 3.108 | 5.262 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 1.056 | 1.154 | 419 | 2.958 | 4.214 | 1.219 | 1.213 | 7.807 | 3.639 | 3.619 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Citotest Srl